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Abstract
Background: Bacterial meningitis in children is a life-threatening problem resulting in severe morbidity and
mortality. For the prompt initiation of antibacterial therapy, rapid and reliable diagnostic methods are of utmost
importance. Therefore, this study was designed to find out the rate of bacterial pathogens of meningitis from
suspected cases by performing conventional methods and latex agglutination.
Methods: A descriptive type of study was carried out from May 2012 to April 2013. Cerebrospinal fluid (CSF)
specimens from 252 suspected cases of meningitis were subjected for Gram staining, bacterial culture and latex
agglutination test. The identification of growth of bacteria was done following standard microbiological methods
recommended by American Society for Microbiology. Antibiotic sensitivity testing was done by modified Kirby-Bauer
disk diffusion method.
Results: From the total 252 suspected cases, 7.2 % bacterial meningitis was revealed by Gram staining and culture
methods whereas latex agglutination method detected 5.6 %. Gram-negative organisms contributed the majority of
the cases (72.2 %) with Haemophilus influenzae as the leading pathogen for meningitis. Overall, 33.3 % mortality rate
was found.
Conclusions: In conclusion, a significant rate of bacterial meningitis was found in this study prompting concern for
national wide surveillance.
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Background
The presence of microorganisms in normally sterile
body fluid specimens may be representative of life-
threatening infections [1]. Infection of normally sterile
body fluids often results in severe morbidity and mor-
tality; therefore, rapid and accurate microbiological as-
sessment of these specimens is important to successful
patient management. Any microorganism found in a
normally sterile site must be considered significant, and
all isolates must be reported [2].
Bacterial meningitis, an infection of the membranes
(meninges) and cerebrospinal fluid (CSF) surrounding the
brain and spinal cord, is a major cause of death and disabil-
ity worldwide [3]. In recent years, despite improvements in
antimicrobial therapy and intensive care support, overall
mortality rates related to bacterial meningitis of around 20
to 25 % have been reported by major centers [4, 5]. Early
clinical suspicion and implementation of appropriate anti-
microbial therapy are critical to minimize adverse out-
comes [6–8]. Rapid diagnosis by Gram staining for a
suspected infectious organism from a sterile body fluid is a
major responsibility of clinical microbiology laboratory. In
addition to suggesting a diagnosis, it guides clinicians in
the choice of antibiotics [9–11]. Gram stain usually yields
organisms, allowing presumptive diagnosis in the majority
of cases with sensitivity of greater than 90 %, subsequently
confirmed within 1 or 2 days by culture [12].
The current standard for the identification of bacterial
meningitis in developing countries remains to be micro-
scopic examination and consequent culture of CSF.
However, this approach might have some disadvantages
with regard to the desired rapidity and sensitivity [12],
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and the risk of false negative result is high because only
a small number of microorganisms may be present in
the specimens [13, 14]. An etiological diagnosis of bac-
terial meningitis may be possible in less than 1 hour by
latex agglutination, co-agglutination, or counter-immuno-
electrophoresis. These methods have sensitivity compar-
able to those of microscopy and culture [15–18], but are
considerably less sensitive than Enzyme Linked Immuno-
sorbent Assay (ELISA) or radio-immunoassay [19, 20].
Rapid diagnosis and empirical therapy of meningitis on
the basis of clinical findings are important, because stable
neurological sequel such as hearing loss, mental retard-
ation, seizures, and behavioral changes may occur in up to
one-half of survivors [21].
Therefore, the aim of this study were to document the
bacterial causative agents in suspected meningitis cases
by performing culture and rapid test, their antimicrobial
susceptibility profile and to find out the mortality rate.
Methods
The descriptive type of study was carried out in the
Public Health Research Laboratory, Institute of
Medicine, Tribhuvan University Teaching Hospital
(TUTH), Maharajgunj, Kathmandu during one year
period from May 2012 to April 2013. Being the leading in-
stitute of Nepal, TUTH provides the best care at tertiary
level to every patient through integrated clinical services
at an affordable cost to every community of Nepal.
Study populations
A total of 252 CSF specimens, during one year study
period, were collected from the patients of age up to
15 years having clinical features suggestive of meningitis.
Collection and processing of CSF samples
After obtaining the consent, the CSF specimens were
collected by medical officers in a sterile tube. The vol-
ume and gross appearance i.e., consistency, presence of
blood and the color of CSF were noted. CSF specimen
greater than 1 ml was centrifuged at the rate of 2,500
revolutions per minute (rpm) for 10 minutes to concen-
trate if any organisms were present. The sediment was
used for culture as well as for Gram staining. The super-
natant was saved for detection of antigen by latex agglu-
tination commercial kit (BIO-RAD, Pastorex™ Meningitis).
If CSF specimen less than 1 ml was received, the specimen
was inoculated directly to the culture media.
Bacteriological assays
All the specimens were collected from the patients of a
single tertiary care hospital and thus, the specimens
were transported to the laboratory within half an hour.
CSF specimen was inoculated in MacConkey agar (MA),
blood agar (BA) and chocolate agar (CA) plates. The
MA and BA plates were incubated overnight at 37 °C
aerobically and the CA plates were incubated up to
48 hours at 37 °C in 5 % CO2 atmosphere (i.e., in a
CO2-incubator or a candle-jar) which improved growth
of capnophilic bacteria. The bacterial growth obtained
was examined for colonial as well as Gram staining char-
acteristics and identification was done following standard
microbiological methods recommended by American
Society for Microbiology (ASM) [2]. A purity plate was
employed to ensure that the inoculum used for the bio-
chemical tests was pure. The bacterial growths were also
subjected for the latex agglutination for grouping of bac-
terial strains according to the manufacturer instructions as
described below.
Grouping of Neisseria meningitidis (A, B and C only),
Haemophilus influenzae, Escherichia coli and Streptococcus
pneumoniae
Bacterial suspension was prepared by taking 2–3 colonies
of Neisseria meningitidis (N. meningitidis), Haemophilus
influenzae (H. influenzae) and Escherichia coli (E. coli) and
10–12 colonies of Streptococcus pneumoniae (S. pneumo-
niae) and emulsifying in 30 microlitres (μl) of sterile nor-
mal saline on a disposable card. One drop of latex reagent
was added to the bacterial suspension and mixed properly
using a rod. The whole preparation was then rotated at
120 revolutions per minute (rpm) and observed for the ap-
pearance of any clear agglutination in less than 2 min. The
identification of the species was confirmed using conven-
tional biochemical tests.
Grouping of group B streptococcus (Streptococcus agalactiae)
Five colonies of group B streptococcus were suspended
in 2 ml of Todd Hewitt broth and incubated for 2–3
hours at 37 °C in a water bath. Then, centrifuged for
5 min at 30,000 rpm. One drop of supernatant (40–50 μl)
was placed on the disposable card and one drop of latex
reagent was added on the drop of supernatant. The whole
preparation was mixed with a rod and rotated at 120 rpm.
It was observed for the appearance of any clear agglutin-
ation within less than 1 min. The identification of the spe-
cies was confirmed using conventional biochemical tests.
Antibiotic susceptibility test (AST)
All the isolates grown were subjected for antibiotic sus-
ceptibility testing by modified Kirby-Bauer disk diffusion
method in compliance with Clinical and Laboratory
Standards Institute (CLSI) guidelines using Mueller-
Hinton agar standard media. The inhibition zone stan-
dards for antimicrobial susceptibility were considered
from tables of interpretative zone diameters of CLSI [22].
Antibiotic disks (HiMedia Laboratories, Pvt. Limited,
India) used were: ampicillin (10 μg), amoxicillin (10 μg),
chloramphenicol (30 μg), ciprofloxacin (5 μg), rifampicin
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(15 μg), tetracycline (10 μg), imipenem (10 μg), co-
trimoxazole (25 μg), vancomycin (30 μg). Staphylococcus
aureus ATCC 25923 and E. coli 25922 were used as con-
trol organisms for antibiotic susceptibility testing.
Latex agglutination test from the supernatant
Latex agglutination is an immunological technique based
on the detection of soluble antigens released by the
causative organisms into biological fluids like CSF dur-
ing the infection by using latex particles coated with spe-
cific homologous antibodies, permits a more rapid
diagnosis. The soluble antigens that can be detected are
the polysachharides specific for certain serogroups or se-
rotypes: S. pneumoniae (83 types), H. influenzae type b,
N. meningitidis (group A, B, C and Y/W135), E. coli K1,
and group B streptococcus (Streptococcus agalactiae). In
the presence of homologous antibody, latex particles ag-
glutinate, in the absence of antigen they remain in a
homogenous suspension.
In the latex agglutination test, for the detection of an-
tigens, one drop (40–50 μl) of the supernatant of CSF
specimen was taken on agglutination card and one drop
of each latex reagent was added. The specimen and the
reagents were mixed using a rod (separate rod for each
reagent). The whole preparations were then rotated at
120 rpm for 10 min. Any visible agglutination was noted
and considered as positive.
Ethical aspects
The verbal consent in local language for this study was
taken from the guardians of participating children, then,
written informed consent was obtained. This study was
approved by the Institutional Review Committee (IRC)
of Chitwan Medical College, Bharatpur, Chitwan, Nepal.
Data analysis
All the results were entered in the worksheet of statis-
tical package for social science (SPSS) software-16.0 ver-
sion and the results were determined.
Results
Total and positive cases
During one year study period, 252 CSF samples were
collected and processed for the detection of bacterial
pathogens by culture and antigen detection method. The
positive bacterial growth was obtained from 18 (7.2 %)
cases and latex agglutination test for detection of antigen
revealed 14 (5.6 %) positive cases (Table 1).
Age-wise distribution of cases
The highest number of suspected cases were found in
the age group of more than 60 months (36.9 %) followed
by 27.4 % in age group of less than 1 month while the
lowest (10.3 %) was found in the age group of 37–60
months. Likewise, the highest rate of culture positive
cases were found in the age group of less than 1 month,
1–12 months and more than 60 months with 27.8 % in
each age group while the lowest rate (5.5 %) was ob-
served in age group of 13–36 months (Table 1).
Gender-wise distribution of patients
Among total enrolled cases, in this study, 139 (55.2 %) were
males and 113 (44.8 %) were females. Out of total 18 (7.2
%) positive cases, male and female showed equal distribu-
tion of culture positive cases that is 9 (3.6 %) (Table 2).
Comparison of detection methods
From 252 clinical specimens of CSF, examined for Gram
staining, culture and latex agglutination test, Gram stain-
ing and culture detected 18 (7.1 %) positive cases whereas
latex agglutination test detected 14 (5.6) specimens posi-
tive for bacterial antigen. All latex agglutination test posi-
tive cases showed bacterial growth in culture (Table 3).
Distribution of bacterial isolates
Gram-positive as well as Gram-negative organisms were
isolated from CSF specimens. Gram-negative aerobic rods
accounted for 11 cases (61.1 %) and Gram-negative cocci
occupied 2 cases (11.1 %) while Gram-positive cocci con-
stituted the remaining 5 cases (27.8 %). The highest fre-
quency and distribution was shown by H. influenzae (38.9
%) followed by group B streptococcus and E. coli each con-
stituting 16.7 % while Pseudomonas spp. was found in 1
(5.5 %) case (Table 4).
Antibiotic susceptibility pattern of isolates
Among the various antibiotics tested, tetracycline was
found the most effective drug against Gram-positive as
Table 1 Age-wise distribution of total and positive cases
Age group Total suspected cases Positive cases
No. % No. %
<1 month 69 27.4 5 27.8
1–12 months 29 11.5 5 27.8
13–36 months 35 13.9 1 5.5
37–60 months 26 10.3 2 11.1
>60 months 93 36.9 5 27.8
Total 252 100 18 100
Table 2 Gender-wise distribution of total and positive cases
Sex Total suspected cases Positive cases
No. % No. %
Male 139 55.2 9 3.6
Female 113 44.8 9 3.6
Total 252 100 18 7.2
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well as Gram-negative isolates. Resistance to tetracycline
was only noted in H. influenzae (14.3 %). All of the S.
pneumoniae, E. coli and Pseudomonas spp. were suscep-
tible to chloramphenicol and ciprofloxacin while consid-
erable rate of resistance (50 %) to ceftriaxone was only
found in S. pneumoniae (Table 5).
Mortality rate
Among total positive cases, mortality rate was found to
be 33.3 %. Half (50 %) of the cases infected with N.
meningitidis and S. pneumoniae were died followed by
H. influenzae (42.9 %) and E. coli (33.3 %) (Table 6).
Discussion
The meningitis can be caused by bacterial or viral patho-
gens but the viral meningitis is usually less severe and its
frequency increases slightly in the summer months be-
cause of greater exposure to viruses [23]. Despite ad-
vances in management, bacterial meningitis remains a
life threatening infection with high rates of morbidity
and mortality [24]. Early clinical suspicion and imple-
mentation of appropriate antimicrobial therapy are crit-
ical to minimize adverse outcomes. CSF culture is
considered the diagnostic reference standard for bacter-
ial meningitis, and bacterial isolation is important for
antimicrobial susceptibility testing and molecular epi-
demiology [6–8]. Molecular techniques are quickly be-
coming the gold standard for both bacterial and viral
meningitis but these methods are not easily available in
Nepal because of their high cost. Therefore, standard
used for our comparisons was a positive result by any of
the three test methods i.e. by Gram’s staining method,
CSF culture and latex agglutination. Of the 252 CSF
samples, only 18 (7.2 %) revealed significant growth in
this study. In similar studies conducted in Nepal, signifi-
cant growths of various isolates were also detected by
Shah et al. (3.7 %) in 2001 [25] and Ansari et al. (4.4 %)
in 2011 [26]. Proportionately, a high rate of bacterial
growth (17.7 %) was detected by Wu et al. in 2013 [27].
The rate of positive yield of bacterial meningitis depends
on a number of factors for examples, the time of lumber
puncture, the probable number of bacteria in Gram’s
stained preparation of CSF and the antibacterial therapy
prior to lumberpuncture [28].
In this study, among the enrolled cases, up to
12 months of age was found to be the most vulnerable
age group in children accounting for 55.6 % of total
positive cases. Similarly, the higher rate of meningitis
(32.1 %) was also detected in children of 6–12 months
of age by Joshi Batajoo from Nepal [29]. The higher rate
of meningitis in early age children may be because of
the underdeveloped immune system.
Bacteriological profile (Gram staining and culture re-
sult) of CSF facilitates the choice of antibiotic therapy
[30]. CSF culture sensitivities typically range between 70
to 90 % [6–8] with variation in case inclusion criteria, pa-
tient characteristics, laboratory practices, and spectrum of
bacterial pathogens likely contributing to the observed dif-
ferences [27]. Gram staining, a mainstay of bacterial men-
ingitis diagnosis, is widely available, inexpensive and rapid
[24]. Some authors recommend using latex agglutination
tests to detect bacterial capsular antigens in patients with
suspected bacterial meningitis who have been receiving
antibiotics at the time the lumbar puncture is performed.
These tests are not specific, however, and they identify
very few cases of bacterial meningitis not already detected
by CSF culture [31]. In our study, the latex agglutination
Table 3 Comparison of different methods for the detection of
positive cases
Method No. of specimens No. of positive cases (%)
Gram staining 252 18 (7.2)
Culture 252 18 (7.2)
Latex agglutination 252 14 (5.6)
Table 4 Age wise distribution of bacterial isolates
Organisms <1 month 1–12 months 13–36 months 37–60 months >60 months Total
No. (%) No. (%) No. (%) No. (%) No. (%) No. (%)
Gram-positive 3 (60) 0 1 (20) 0 1 (20) 5 (27.8)
Group B streptococcus 1 (33.3) 0 1 (33.3) 0 1 (33.3) 3 (16.7)
S. pneumoniae 2 (100) 0 0 0 0 2 (11.1)
Gram-negative 2 (15.4) 5 (38.5) 0 2 (15.4) 4 (30.8) 13 (72.2 %)
H. influenzae 2 (28.6) 3 (42.8) 0 1 (14.3) 1 (14.3) 7 (38.9)
N. meningitidis 0 0 0 0 2 (100) 2 (11.1)
E. coli 0 2 (66.7) 0 0 1 (33.3) 3 (16.7)
Pseudomonas spp. 0 0 0 1 (100) 0 1 (5.5)
Total 5 (27.8) 5 (27.8) 1 (5.5) 2 (11.1) 5 (27.8) 18 (100)
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test showed sensitivity of 77.8 % when compared with
Gram staining and bacterial culture. This may be due to
that currently available latex agglutination antigen detec-
tion test kits have several limitations [32–34]. Despite it is
simple to perform, does not require special equipment,
and is rapid (results are available in ≤15 min). Depending
on the meningeal pathogen, latex agglutination has shown
good sensitivity in detecting the antigens of common
meningeal pathogens: 78-100 % for H. influenzae type b,
67–100 % for S. pneumoniae, 69–100 % for S. agalactiae,
and 50–93 % for N. meningitidis. However, a negative bac-
terial antigen test result does not rule out infection caused
by a specific meningeal pathogen [35].
Etiology of bacterial meningitis varies from place to
place [36, 37]. Of the 252 samples being only 7.2 % cul-
ture positivity, Gram-positive bacteria was isolated from
5 (27.8 %) of culture positive cases and Gram-negative
from 13 (72.2 %) cases which was in accordance with
the study conducted by Ghotaslou et al. from Iran in
2012 [38].
In infants and young children worldwide, S. pneumoniae
is the common Gram-positive agent for bacterial meningi-
tis whereas N. meningitidis and H. influenzae type b (Hib)
are the most common Gram-negative causes of bacterial
meningitis. Among children older than 5 years of age and
adolescents, S. pneumoniae and N. meningitidis are the
predominant causes of bacterial meningitis [39, 40].
Immunization is the most effective means of prevention of
bacterial meningitis in children. Universal immunization
with the conjugated vaccines has been associated with a
reduction of more than 99 % in invasive diseases caused
by H. influenzae type b in developed countries [41]. The
costs and implementation of these vaccines in developing
countries pose daunting problems. The Child Health
Division (CHD) of the Department of Health Services
(DOHS) of Nepal introduced its regular immunization
program by November of 2014 to prevent pneumonia and
meningitis caused by 23 pneumococcal strains out of more
than 80 strains. But it was not possible to cover the whole
nation at once [42]. Among culture positive organisms, H.
influenzae (38.9 %) was reported as a leading cause of
meningitis followed by group B streptococcus (16.1 %) and
E. coli (16.1 %) in this study. Out of 7H. influenzae posi-
tive cases, 5 (71.4 %) was detected in children below
12 months. Despite of the H. influenzae type b (Hib) vac-
cination, it has been found as a leading cause of meningi-
tis. The vaccination coverage and H. influenzae capsular
types other than b could be the reason. However, the in-
creased rate in some ethnic groups and some families, and
the observation that siblings of patients with meningitis
can have deficient antibody synthesis against H. influen-
zae, indicate that genetic predisposition to infection prob-
ably exists [43]. The risk of acquiring a secondary case of
haemophilus or meningococcal disease is greatly increased
after exposure to primary infection in the household [44].
Although, group B streptococcus is a leading cause of
meningitis in neonates, this organism has been recognized
with increasing frequency as a substantial cause of menin-
gitis in later age groups [45]. In this study, we also identi-
fied a single case of meningitis with group B streptococcus
in later age group. It has been defined that the serious
Table 5 Antibiotic resistance rate of different isolates
Antibiotics S. pneumoniae (2) Group B streptococcus (3) H. influenzae (7) N. meningitidis (2) E. coli (3) Pseudomonas spp. (1)
No. (%) No. (%) No. (%) No. (%) No. (%) No. (%)
Ampicillin 2 (100) - 2 (28.6) 2 (100) - -
Ceftriaxone 1 (50) 0 1 (14.3) 0 0 0
Chloramphenicol 0 1 (33.3) 1 (14.3) 1 (50) 0 0
Ciprofloxacin 0 1 (33.3) 3 (42.9) 0 0 0
Rifampicin - - 2 (28.6) 0 - -
Amoxicillin - - 1 (14.3) - - -
Tetracycline 0 0 1 (14.3) - 0 0
Imipenam - - - 0 1 (33.3) 0
Cotrimoxazole 2 (100) 2 (66.7) 3 (42.9) 2 (100) 2 (66.7) 1 (100)
Vancomycin 0 1 (33.3) - - - -
Table 6 Mortality rate among culture positive cases
Organisms Total positive cases Live Death
No. No. (%) No. (%)
H. influenzae 7 4 (57.1) 3 (42.9)
N. meningitidis 2 1 (50.0) 1 (50.0)
S. pneumoniae 2 1 (50.0) 1 (50.0)
Group B streptococcus 3 3 (100) 0
E. coli 3 2 (66.7) 1 (33.3)
Pseudomonas spp. 1 1 (100) 0
Total 18 12 (66.7) 6 (33.3)
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underlying diseases could be the reason but in this study
we could not evaluate the predisposing factors for the
meningitis by group B streptococcus.
Once the bacterial meningitis is suspected, there
should be no delay in starting appropriate empiric anti-
biotics. This requires knowledge of the likely pathogens
and their antibiotic susceptibilities. In this study, the an-
tibiotics like tetracycline, chloramphenicol and ciproflox-
acin were found most effective against Gram-positive as
well as Gram-negative whereas, vancomycin was most
effective against Gram-positive while ceftriaxone was the
most effective against Gram-negative isolates. The result
of our study corroborates with Mastro et al. (1991) who
reported only 2.8 % of strains resistance to chloram-
phenicol [46]. Ampicillin and cotrimoxazole were the
least effective antibiotics against the isolates. All S. pneu-
moniae and N. meningitidis isolates were resistant to
ampicillin and cotrimoxazole in our study. By contrast,
higher resistance rate (64.1 %) to cotrimoxazole was also
reported by Saha et al. in 1997 from Nepal [47]. The in-
creased rate of cotrimoxazole resistance can be possibly
be correlated with the wide use of this antibiotic in the
communities because of its dose convenience, cost ef-
fectiveness, easy availability and the practice of prescrib-
ing it to treat suspected bacterial pneumonia cases.
Out of 18 infected children, 6 (33.3 %) children died
from the bacterial meningitis. Case-fatality rate was most
common in meningitis caused by Neisseria spp. (50.0 %)
and S. pneumoniae (50.0 %) followed by H. influenzae
(42.9 %) and E. coli (33.3 %) in this study. The mortality
rate of 4 to 10 % due to bacterial meningitis in children
has been revealed in more recent studies [48] however, a
similar high mortality rate of 48 % was also detected in a
study by Al-Harthi et al. from Saudi Arabia [49].
A differential diagnosis of meningitis requires the dif-
ferentiation of viral, tuberculous and acute bacterial
meningitis and prevention from transmission of dis-
eases, vaccination against the organism, their chemo-
prophylaxis are suggested in order to prevent the
disease from being transmitted as well as a cause for
mortality of children.
Conclusion
The bacterial meningitis is abundant in children up to
15 years of age as revealed in the present study. A variety
of Gram positive as well as Gram negative organisms
was documented. This situation calls for the longitudinal
nation-wide surveillance for bacterial meningitis to
document the real scenario regarding prevalent strains
of bacterial pathogens in order to implement or change the
vaccine types. We also recommend health education of the
public to improve awareness on adequate immunization
and appropriate drug management.
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